Skip to main content

Find Clinical Trials

Home
Conditions
DNA Virus Infections

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,913 public trials 504 recruiting studies

Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

NCT04239521

Conditions: Acute Bronchitis, Allergic Rhinitis, Alopecia, +151 more
Locations: Momentum Data Ltd London, United Kingdom

View Trial Details

Completed

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

NCT00864227

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations: City of Hope National Medical Center Duarte, California, United States

University of Florida College of Medicine, Shands Gainesville, Florida, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

View all 16 locations

View Trial Details

Completed

Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study

NCT03545334

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +21 more
Locations: Inselspital, University Hospital Bern, University of Bern Bern, Canton of Bern, Switzerland

View Trial Details

Completed

A Clinical Trial of PEGIFNα1b in Chinese Healthy Adults

NCT05639803

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: The first affiliated hospital of bengbu medical college Bengbu, Anhui, China

View Trial Details

Completed

A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

NCT02643303

Conditions: Adenocarcinoma, Bladder Cancer, Breast Cancer, +65 more
Locations: Research Facility Atlanta, Georgia, United States

Research Facility Lebanon, New Hampshire, United States

Research Facility Buffalo, New York, United States

Research Facility New York, United States

View Trial Details

Completed

Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum Contagiosum

NCT05634460

Conditions: DNA Virus Infections, Infections, Molluscum Contagiosum, +6 more
Locations: CMH Abbottabad, KPK, Pakistan

View Trial Details

Completed

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

NCT01947140

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Columbia University Irving Medical Center New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

NCT01519960

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Univ of California SF, Benioff Children's Hospital; Pediatrics, Gastro, Hepatology & Nutrition San Francisco, California, United States

Johns Hopkins Hospital - Pediatric Gastroenterology Baltimore, Maryland, United States

Children's Hospital Boston-Harvard Medical School; Division of Gastoenterology Boston, Massachusetts, United States

St. Louis University - Cardinal Glennon Children's Medical Center St Louis, Missouri, United States

View all 39 locations

View Trial Details

Completed

Merkel Positron Emission Tomography (PET) Protocol

NCT01013779

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Campbelltown Campbelltown, New South Wales, Australia

Liverpool Hospital Liverpool, New South Wales, Australia

Royal Prince Alfred Sydney, New South Wales, Australia

Calvary Mater Newcastle Waratah, New South Wales, Australia

View all 13 locations

View Trial Details

Completed

An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection

NCT03361956

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: The Office of Franco Felizarta, MD Bakersfield, California, United States

Orlando Immunology Center Orlando, Florida, United States

Rush University Medical Center Chicago, Illinois, United States

Tulane Medical Center (TMC) New Orleans, Louisiana, United States

View all 76 locations

View Trial Details